|
Clinical
& Regulatory Strategies
|
|
WHO
WE ARE
|
| Adeoye
Y. Olukotun, MD, MPH Chief Executive Officer Dr. Olukotun is a Board Certified Cardiologist. He received his medical training at Albert Einstein College of Medicine and obtained a Masters of Public Health from Harvard University School of Public Health. From 1996 to 2000 Oyé was Vice President and Chief Medical Officer for Mallinckrodt, Inc, a human healthcare organization with headquarters in St. Louis, MO. Prior to that he was employed by Bristol-Myers Squibb in positions of increasing responsibility. Throughout his industry career, Oyé has played key roles in the submission of more than fourteen New Drug Applications, Premarket Authorization Applications, and 510k Applications. He has published more than thirty articles in peer-reviewed scientific journals. Dr. Olukotun can be contacted at oye.olukotun@clinregstrategies.com |
||||
| OUR CLIENTS ARE: | ||||
| Berlex Corporation, Montville, NJ Corning Corporation, Corning, NY CWH Associates, New York, NY McHugh Consulting, Pennington, NJ NeoRx Corporation, Seattle, WA NitroMed, Inc., Bedford, MA Kureha Chemical, Tokyo, Japan |
|
|||